Development of cancer reversion technology to reprogram - 바이오및뇌공학과 조광현 연구책임자 (ENG) скачать в хорошем качестве

Development of cancer reversion technology to reprogram - 바이오및뇌공학과 조광현 연구책임자 (ENG)

[2022 KAIST Annual Report] Development of cancer reversion technology to reprogram malignant breast cancer cells into endocrine therapy vulnerable cells - 바이오및뇌공학과 조광현 연구책임자 (ENG) Summary | Tumorigenesis has been considered an irreversible biological phenomenon in humans. During mammary development, tumorigenesis can drive cancer cells to become more malignant and promote epithelial-mesenchymal transition. In this study, we developed a reverse control technology for reprogramming malignant breast cancer cells to less invasive cells vulnerable to endocrine therapy. Read full contents | https://archives.kaist.ac.kr/eng/rese... -- This is KAIST ARCHIVES, a record portal where you can see all KAIST records at a glance. From the history of KAIST, to interviews with people who have achived the school, to representative research achievements and student records. Subscribe to KAIST ARCHIVES and get more news! KAIST Website: https://www.kaist.ac.kr/ KAIST Archive Youtube:    / @kaistarchives2910   KAIST Archive Website: https://archives.kaist.ac.kr